These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4746447)

  • 21. [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.
    Watson M; Roeske WR; Yamamura HI
    Life Sci; 1982 Nov; 31(18):2019-23. PubMed ID: 6897437
    [No Abstract]   [Full Text] [Related]  

  • 22. Drinking and cholinergic mechanisms in the abstinence after chronic barbital treatments.
    Wahlström G
    Scand J Psychol; 1982; Suppl 1():79-84. PubMed ID: 7187992
    [No Abstract]   [Full Text] [Related]  

  • 23. Alterations in atropine sites of the brain of rats as a function of age.
    James TC; Kanungo MS
    Biochem Biophys Res Commun; 1976 Sep; 72(1):170-5. PubMed ID: 985464
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of selected muscarinic cholinergic antagonists on [3H]acetylcholine release from rat hippocampal slices.
    Pohorecki R; Head R; Domino EF
    J Pharmacol Exp Ther; 1988 Jan; 244(1):213-7. PubMed ID: 3335998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of cholinergic mechanisms in the central cardiovascular actions of nicardipine in dogs.
    Montastruc JL; Dang Tran L; Huchet-Brisac AM; Chelly J; Rostin M; Montastruc P
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):212-6. PubMed ID: 3426347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fate of intracerebroventribular injection of atropine and methylatropine in relation to their pharmacological effects.
    Albanus L; Aquilonius SM; Sundwall A; Winbladh B
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):81-96. PubMed ID: 5819577
    [No Abstract]   [Full Text] [Related]  

  • 28. Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography.
    Kuhar M; Yamamura HI
    Brain Res; 1976 Jul; 110(2):229-43. PubMed ID: 938940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gastric acid secretion by cholinergic stimulation of the lateral hypothalamic area.
    Gontijo JA; Silva-Netto CR; Furtado MR
    Braz J Med Biol Res; 1990; 23(3-4):361-5. PubMed ID: 2094549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and metabolism of H3-atropine in mice.
    Albanus L; Hammarström L; Sundwall A; Ullberg S; Vangbo B
    Acta Physiol Scand; 1968 Aug; 73(4):447-56. PubMed ID: 5708172
    [No Abstract]   [Full Text] [Related]  

  • 31. Ontogenesis of muscarinic receptor sites in rat brain [proceedings].
    Hiley CR
    Br J Pharmacol; 1976 Nov; 58(3):427P-428P. PubMed ID: 990614
    [No Abstract]   [Full Text] [Related]  

  • 32. Deficits in passive-avoidance learning following atropine in the developing rat.
    Blozovski D; Cudennec A; Garrigou D
    Psychopharmacology (Berl); 1977 Oct; 54(2):139-43. PubMed ID: 412208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo identification of muscarinic cholinergic receptor binding in rat brain.
    Yamamura HI; Kuhar MJ; Snyder SH
    Brain Res; 1974 Nov; 80(1):170-6. PubMed ID: 4421615
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of cholinergic and other pharmacologic agents on brain monophosphoinositide turnover in vivo.
    Margolis RU; Heller A
    J Pharmacol Exp Ther; 1966 Feb; 151(2):307-12. PubMed ID: 5932606
    [No Abstract]   [Full Text] [Related]  

  • 35. Muscarinic cholinergic agonists at picomolar to nanomolar concentrations produce contractions of isolated rat aortae.
    Cheng JB
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):145-8. PubMed ID: 6755589
    [No Abstract]   [Full Text] [Related]  

  • 36. Binding characteristics of [3H]quinupramine to rat brain membrane fractions.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Sep; 45(1):27-36. PubMed ID: 2824895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atropine, pilocarpine and morphine on footshock-induced aggressive behaviour in rats after lesion of hippocampal pyramidal cells with kainic acid.
    Milart P; Turski W; Czuczwar S; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1982; 37():35-43. PubMed ID: 6927308
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of atropine on event-related slow potentials in the rat.
    Ebenezer IS
    Eur J Pharmacol; 1986 Jan; 120(3):371-4. PubMed ID: 3948926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of guanyl-5'-yl imidodiphosphate and sodium on muscarinic receptor binding in the rat brain and longitudinal muscle of the rat ileum.
    Ehlert FJ; Roeske WR; Rosenberger LB; Yamamura HI
    Life Sci; 1980 Jan; 26(3):245-52. PubMed ID: 7360006
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasoactive intestinal polypeptide and muscarinic receptors: supersensitivity induced by long-term atropine treatment.
    Hedlund B; Abens J; Bartfai T
    Science; 1983 Apr; 220(4596):519-21. PubMed ID: 6132446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.